MY149089A - Succinate and malonate salt of trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament - Google Patents

Succinate and malonate salt of trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament

Info

Publication number
MY149089A
MY149089A MYPI20043353A MYPI20043353A MY149089A MY 149089 A MY149089 A MY 149089A MY PI20043353 A MYPI20043353 A MY PI20043353A MY PI20043353 A MYPI20043353 A MY PI20043353A MY 149089 A MY149089 A MY 149089A
Authority
MY
Malaysia
Prior art keywords
phenylindan
trimethylpiperazine
chloro
succinate
trans
Prior art date
Application number
MYPI20043353A
Inventor
Heidi Lopez De Diego
Ole Nielsen
Lone Munch Ringgard
Henrik Svane
Allan Dahl
Mark Howells
Lars Ole Lyngsoe
Benny Bang-Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MY149089A publication Critical patent/MY149089A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18—Polycyclic aromatic halogenated hydrocarbons
    • C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

4-((1R, 3S)-6-CHOLORO-3-PHENYLINDAN-1-YL)-1, 2, 2-TRIMETHYLPIPERAZINE HYDROGEN SUCCINATE OR HYDROGEN MALONATE, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE SALTS AND THE MEDICAL USE THEREOF, INCLUDING FOR THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS. ALSO DESCRIBED ARE METHODS FOR THE PREPARATION OF 4-((1R, 3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-1, 2, 2-TRIMETHYLPIPERAZINE AND MEDICAL USES THEREOF.
MYPI20043353A 2003-08-18 2004-08-18 Succinate and malonate salt of trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament MY149089A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301180 2003-08-18
DKPA200301305 2003-09-11

Publications (1)

Publication Number Publication Date
MY149089A true MY149089A (en) 2013-07-15

Family

ID=58707237

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI20082882A MY154535A (en) 2003-08-18 2004-08-18 Succinate and malonate salt of trans-4-((1r,3s)-6-chloro-3-phenylindan-1-y1)-1,2,2-trimethylpiperazine and the use as a medicament
MYPI20043353A MY149089A (en) 2003-08-18 2004-08-18 Succinate and malonate salt of trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MYPI20082882A MY154535A (en) 2003-08-18 2004-08-18 Succinate and malonate salt of trans-4-((1r,3s)-6-chloro-3-phenylindan-1-y1)-1,2,2-trimethylpiperazine and the use as a medicament

Country Status (16)

Country Link
KR (2) KR101227789B1 (en)
CN (1) CN101935305B (en)
AR (2) AR045278A1 (en)
AT (1) ATE552247T1 (en)
DK (1) DK1658277T3 (en)
EA (2) EA014641B1 (en)
ES (1) ES2383369T3 (en)
HK (2) HK1096089A1 (en)
IS (1) IS8264A (en)
ME (1) MEP2408A (en)
MY (2) MY154535A (en)
PT (1) PT1658277E (en)
RS (3) RS20060083A (en)
SG (2) SG148183A1 (en)
SI (1) SI1658277T1 (en)
TW (2) TWI403505B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI453198B (en) * 2005-02-16 2014-09-21 Lundbeck & Co As H Process for making the trans-1-( (1r , 3s)- 6-chloro - 3 -phenylindan-1- yl ) - 3 , 3 - dimethylpiperazine and salts thereof and for making 4 -((1r , 3s )-6- chloro- 3- phenylindan -1- yl )-1, 2 , 2 -trimethylpiperazine and salts thereof
PL2720989T3 (en) 2011-06-20 2017-05-31 H. Lundbeck A/S Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50867B1 (en) * 1980-02-29 1986-08-06 Kefalas As Indane derivatives
DK55192D0 (en) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindene derivatives

Also Published As

Publication number Publication date
EA014641B1 (en) 2010-12-30
ATE552247T1 (en) 2012-04-15
HK1096089A1 (en) 2007-05-25
MY154535A (en) 2015-06-30
AR045278A1 (en) 2005-10-19
KR101227789B1 (en) 2013-01-30
IS8264A (en) 2006-01-26
SI1658277T1 (en) 2012-10-30
CN101935305A (en) 2011-01-05
KR20060066094A (en) 2006-06-15
RS20060121A (en) 2008-09-29
ES2383369T3 (en) 2012-06-20
AR045279A1 (en) 2005-10-19
RS20060083A (en) 2008-08-07
TWI403505B (en) 2013-08-01
SG148183A1 (en) 2008-12-31
TW201111351A (en) 2011-04-01
HK1152699A1 (en) 2012-03-09
EA200600443A1 (en) 2006-08-25
TW200519098A (en) 2005-06-16
DK1658277T3 (en) 2012-06-18
KR20060066104A (en) 2006-06-15
PT1658277E (en) 2012-05-25
MEP2408A (en) 2010-02-10
RS53369B (en) 2014-10-31
CN101935305B (en) 2013-04-10
SG145723A1 (en) 2008-09-29
EA200600441A1 (en) 2006-08-25
TWI388550B (en) 2013-03-11

Similar Documents

Publication Publication Date Title
MXPA06001838A (en) Succinate and malonate salt of trans-4-(ir, 3s)-6 -chloro- 3-phenylindan- 1-yl)-1, 2, 2- trimethylpiperazine and the use as a medicament.
TW200503674A (en) Therapeutic agents
HK1084941A1 (en) Compounds and their use
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
HK1062888A1 (en) Vinyl phenyl derivatives as glk activators
MX2007007027A (en) Piperazinyl pyridine derivatives as anti-obesity agents.
NO20073176L (en) New drugs for the treatment of respiratory diseases
SE0302573D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MXPA05013050A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof.
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
SE0300105D0 (en) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
UA89617C2 (en) Succinate and malonate salt of trans 4-(1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and use thereof as a medicament
MY149089A (en) Succinate and malonate salt of trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
SE0301442D0 (en) Diarylmethylidene piperidine derivatives, preparations therof and uses thereof
SE0301445D0 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
AU2003294952A1 (en) 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
SE0300103D0 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
TW200509915A (en) Novel oxazoles, their manufacture and use as pharmaceutical agents
TW200500356A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301698D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
AU2003298203A1 (en) Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles